Amitiza (lubiprostone) relieves IBS in Phase III « Ion channel News

Amitiza (lubiprostone) relieves IBS in Phase III

Posted on May 20, 2008 by crimsoncanary

Chloride channel agonist Amitiza (lubiprostone) had been shown to significantly relieve symptoms of Irritable Bowel Syndrome with Constipation (IBS-C).

Filed under: Ion Channel | Tagged: amitiza, chloride channel, CIC-2, CIC2, cl channel, lubiprostone, RU-0211, RU0211, SPI-0211, SPI0211, Sucampo, takeda

« YM-758 pharmacokinetics in rats and humans Ion Channel Innovations report on gene therapy for erectile dysfunction »

Leave a Reply